Terms: = Brain cancer AND TOP2A, TOP2, TP2A AND Treatment
15 results:
1. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
[TBL] [Abstract] [Full Text] [Related]
2. The potential bioactive ingredients and hub genes of five TCM prescriptions against lung adenocarcinoma were explored based on bioinformatics.
Liu T; Wei J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2039-2055. PubMed ID: 36914901
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of top2a in human glioblastoma.
Hu Y; Xue Z; Qiu C; Feng Z; Qi Q; Wang J; Jin W; Zhong Z; Liu X; Li W; Zhang Q; Huang B; Chen A; Wang J; Yang N; Zhou W
Cell Cycle; 2022 Sep; 21(17):1842-1855. PubMed ID: 35532155
[TBL] [Abstract] [Full Text] [Related]
4. Multivariate analysis reveals differentially expressed genes among distinct subtypes of diffuse astrocytic gliomas: diagnostic implications.
González-García N; Nieto-Librero AB; Vital AL; Tao HJ; González-Tablas M; Otero Á; Galindo-Villardón P; Orfao A; Tabernero MD
Sci Rep; 2020 Jul; 10(1):11270. PubMed ID: 32647207
[TBL] [Abstract] [Full Text] [Related]
5. Ribosomal protein S11 influences glioma response to top2 poisons.
Awah CU; Chen L; Bansal M; Mahajan A; Winter J; Lad M; Warnke L; Gonzalez-Buendia E; Park C; Zhang D; Feldstein E; Yu D; Zannikou M; Balyasnikova IV; Martuscello R; Konerman S; Győrffy B; Burdett KB; Scholtens DM; Stupp R; Ahmed A; Hsu P; Sonabend AM
Oncogene; 2020 Jul; 39(27):5068-5081. PubMed ID: 32528131
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.
Kopa P; Macieja A; Gulbas I; Pastwa E; Poplawski T
Mol Biol Rep; 2020 Jan; 47(1):67-76. PubMed ID: 31583565
[TBL] [Abstract] [Full Text] [Related]
7. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
[TBL] [Abstract] [Full Text] [Related]
8. Profiles of brain metastases: Prioritization of therapeutic targets.
Ferguson SD; Zheng S; Xiu J; Zhou S; Khasraw M; Brastianos PK; Kesari S; Hu J; Rudnick J; Salacz ME; Piccioni D; Huang S; Davies MA; Glitza IC; Heymach JV; Zhang J; Ibrahim NK; DeGroot JF; McCarty J; O'Brien BJ; Sawaya R; Verhaak RGW; Reddy SK; Priebe W; Gatalica Z; Spetzler D; Heimberger AB
Int J Cancer; 2018 Dec; 143(11):3019-3026. PubMed ID: 29923182
[TBL] [Abstract] [Full Text] [Related]
9. Rethinking medulloblastoma from a targeted therapeutics perspective.
Hashimoto Y; Penas-Prado M; Zhou S; Wei J; Khatua S; Hodges TR; Sanai N; Xiu J; Gatalica Z; Kim L; Kesari S; Rao G; Spetzler D; Heimberger A
J Neurooncol; 2018 Sep; 139(3):713-720. PubMed ID: 29869738
[TBL] [Abstract] [Full Text] [Related]
10. Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.
Aaberg-Jessen C; Fogh L; Sørensen MD; Halle B; Brünner N; Kristensen BW
Pathol Oncol Res; 2019 Jan; 25(1):59-69. PubMed ID: 28963609
[TBL] [Abstract] [Full Text] [Related]
11. Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.
Jandu H; Aluzaite K; Fogh L; Thrane SW; Noer JB; Proszek J; Do KN; Hansen SN; Damsgaard B; Nielsen SL; Stougaard M; Knudsen BR; Moreira J; Hamerlik P; Gajjar M; Smid M; Martens J; Foekens J; Pommier Y; Brünner N; Schrohl AS; Stenvang J
BMC Cancer; 2016 Jan; 16():34. PubMed ID: 26801902
[TBL] [Abstract] [Full Text] [Related]
12. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract] [Full Text] [Related]
13. Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.
Sonabend AM; Carminucci AS; Amendolara B; Bansal M; Leung R; Lei L; Realubit R; Li H; Karan C; Yun J; Showers C; Rothcock R; O J; Califano A; Canoll P; Bruce JN
Neuro Oncol; 2014 Sep; 16(9):1210-9. PubMed ID: 24637229
[TBL] [Abstract] [Full Text] [Related]
14. Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a top2a inhibitor.
Arivazhagan A; Kumar DM; Sagar V; Patric IR; Sridevi S; Thota B; Srividya MR; Prasanna K; Thennarasu K; Mondal N; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
J Neurooncol; 2012 Apr; 107(2):289-97. PubMed ID: 22102081
[TBL] [Abstract] [Full Text] [Related]
15. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
[TBL] [Abstract] [Full Text] [Related]
